A research team at Stanford University has harnessed the power of AI to design phages, raising questions about the future of biotechnology and its applications.

Granisetron Hydrochloride (brand: Shuxing®) is a potent 5?HT? receptor antagonist used in preclinical antiemetic research. Each film-coated tablet contains 1?mg of granisetron. Manufactured by Shaanxi Quantum High-Tech Pharmaceutical Co., Ltd., and approved under China NMPA H10970239 (product code: 86904561000908; barcode: 6944580400284).?? For laboratory research use only.?Please consult the staff for other purposes?

Ruxolitinib Phosphate, marketed as Jakavi® by Novartis, is a selective JAK1/JAK2 inhibitor used in preclinical oncology and hematology models (e.g., myelofibrosis, polycythemia vera). This imported oral tablet formulation contains 5?mg per tablet, 60 tablets per box. Manufactured by Novartis Pharma Stein AG (Switzerland), approved under China NMPA HJ20170134, with organization code 86978672000386 and barcode 6950641900327.?? For laboratory research use only.?Please consult the staff for other purposes?

We introduce CellARC, a synthetic benchmark for abstraction and reasoning built from multicolor 1D cellular automata (CA). Each episode has five support pairs and one query serialized in 256 tokens, enabling rapid iteration with small models while exposing a controllable task space with explicit knobs for alphabet size k, radius r, rule family, Langton's lambda, query coverage, and cell entropy. We release 95k training episodes plus two 1k test splits (interpolation/extrapolation) and evaluate symbolic, recurrent, convolutional, transformer, recursive, and LLM baselines. CellARC decouples generalization from anthropomorphic priors, supports unlimited difficulty-controlled sampling, and enables reproducible studies of how quickly models infer new rules under tight budgets. Our strongest small-model baseline (a 10M-parameter vanilla transformer) outperforms recent recursive models (TRM, HRM), reaching 58.0%/32.4% per-token accuracy on the interpolation/extrapolation splits, while a large closed model (GPT-5 High) attains 62.3%/48.1% on subsets of 100 test tasks. An ensemble that chooses per episode between the Transformer and the best symbolic baseline reaches 65.4%/35.5%, highlighting neuro-symbolic complementarity. Leaderboard: https://cellarc.mireklzicar.com

We introduce CellARC, a synthetic benchmark for abstraction and reasoning built from multicolor 1D cellular automata (CA). Each episode has five support pairs and one query serialized in 256 tokens, enabling rapid iteration with small models while exposing a controllable task space with explicit knobs for alphabet size k, radius r, rule family, Langton's lambda, query coverage, and cell entropy. We release 95k training episodes plus two 1k test splits (interpolation/extrapolation) and evaluate symbolic, recurrent, convolutional, transformer, recursive, and LLM baselines. CellARC decouples generalization from anthropomorphic priors, supports unlimited difficulty-controlled sampling, and enables reproducible studies of how quickly models infer new rules under tight budgets. Our strongest small-model baseline (a 10M-parameter vanilla transformer) outperforms recent recursive models (TRM, HRM), reaching 58.0%/32.4% per-token accuracy on the interpolation/extrapolation splits, while a large closed model (GPT-5 High) attains 62.3%/48.1% on subsets of 100 test tasks. An ensemble that chooses per episode between the Transformer and the best symbolic baseline reaches 65.4%/35.5%, highlighting neuro-symbolic complementarity. Leaderboard: https://cellarc.mireklzicar.com

Bortezomib Injection is a proteasome inhibitor used in preclinical oncology research, particularly for multiple myeloma, mantle cell lymphoma, and various solid tumor models. Each vial contains 1?mg of bortezomib (boronic acid dipeptide), manufactured by Zhengda Tianqing Pharmaceutical Group Co., Ltd., approved under China NMPA H20183261 (product code: 86901523002086).?? For laboratory research use only.?Please consult the staff for other purposes?

Anlotinib hydrochloride (brand: Focus?V®, also known as Catequentinib or AL3818) is a multi-target oral tyrosine kinase inhibitor used in preclinical tumor and angiogenesis studies. It effectively inhibits VEGFR1?3, FGFR1?4, PDGFR?/?, c?Kit, and Ret. Approved in China as a third-line treatment for refractory NSCLC (NMPA H20170134), it also shows activity in sarcoma, RCC, thyroid carcinoma, and more.?? For laboratory research use only.?Please consult the staff for other purposes?

Powerful Website Monitoring & Performance Testing Tools